Phases of clinical research

Biofrontera Inc. Reports Q3 2025 Results: Financial Overview and Strategic Developments

Sanofi’s $1.6 Billion Acquisition of Vicebio: A Bold Step Towards Next-Generation Vaccine Development

Silo Pharma’s Shareholder Update: Progress and Promise in Treatments for PTSD and Chronic Pain

Agios Pharmaceuticals Secures FDA Orphan Drug Designation for Tebapivat: A New Hope in MDS Treatment

Unmasking Potential Marinus Pharmaceuticals Legal Violations: A Deep Dive into Investor Claims and Securities Laws

Revolutionizing the Pharmaceutical Industry: Innoplexus’s Impact with AI in Healthcare and Drug Discovery

Navigating Challenges and Opportunities in Biopharma Funding: Insights from Peter Benton

Biogen’s Bold Expansion: Acquiring HI-Bio for $1.8 Billion to Boost Immunology Portfolio